Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?

Devaux Christian A

doi:10.17352/2455-2976.000122

Journal Articles Cardiology and Cardiovascular Medicine Year : 2020

Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?

(1, 2)

1
2

Devaux Christian A

Function : Author

Microbes évolution phylogénie et infections

Institut Hospitalier Universitaire Méditerranée Infection

Domains

Life Sciences [q-bio] Microbiology and Parasitology Bacteriology Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Microbiology and Parasitology Parasitology Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system Life Sciences [q-bio] Human health and pathology Emerging diseases Life Sciences [q-bio] Human health and pathology Infectious diseases

Isabelle COMBE : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03027634

Submitted on : Friday, November 27, 2020-11:31:23 AM

Last modification on : Tuesday, January 25, 2022-4:28:03 PM

Dates and versions

hal-03027634 , version 1 (27-11-2020)

Identifiers

HAL Id : hal-03027634 , version 1
DOI : 10.17352/2455-2976.000122

Cite

Devaux Christian A. Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?. Cardiology and Cardiovascular Medicine, 2020, 7 (2), pp.101-103. ⟨10.17352/2455-2976.000122⟩. ⟨hal-03027634⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU

10 View

0 Download

Are ACE inhibitors and ARBs more beneficial than harmful in the treatment of severe COVID-19 disease?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share